Forecast: Number of Young High Growth Enterprises (Gazelles) in Basic Pharmaceutical Products in Italy

The number of young high growth enterprises (gazelles) in basic pharmaceutical products in Italy is projected to show steady growth from 2024 to 2028. Starting from a base of 6 enterprises in 2023, the growth is consistent with an expected addition of one enterprise each year, reaching 10 enterprises by 2028. This indicates a positive trend, with a year-on-year growth rate of approximately 16.67% observed each year from 2024 onwards. The compound annual growth rate (CAGR) over this five-year span will reflect this consistent increase.

Looking ahead, key trends to monitor include regulatory changes impacting the pharmaceutical sector, advancements in biotechnology, and potential market demand shifts driven by demographic changes or healthcare innovations. These factors could either bolster or hinder the predicted growth trajectory for high growth enterprises in this industry.